ethambutol has been researched along with Hepatitis B in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, MS; Chung, MP; Kim, H; Koh, WJ; Kwon, OJ; Lee, BH; Suh, GY | 1 |
Chan, CY; Huang, YS; Lee, PY; Lee, SD; Lo, KJ; Ting, LP; Tsai, YT; Wang, YJ; Wu, JC; Yeh, PF | 1 |
3 other study(ies) available for ethambutol and Hepatitis B
Article | Year |
---|---|
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Topics: Adult; Antitubercular Agents; Carrier State; Case-Control Studies; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Incidence; Isoniazid; Male; Pyrazinamide; Retrospective Studies; Rifampin; Risk Factors | 2005 |
Pot shots.
Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; Cattle; CD4 Lymphocyte Count; China; Clarithromycin; Clinical Trials as Topic; Clofazimine; Cryptosporidiosis; Drug Combinations; Ethambutol; Expectorants; Glutathione; Hepatitis B; Humans; Immunoglobulins; Interferon-alpha; Italy; Leprostatic Agents; Mycobacterium avium-intracellulare Infection; Philippines; Protease Inhibitors; Survival Rate; Taiwan; Thymosin; Zidovudine | 1996 |
Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
Topics: Carrier State; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Hepatitis B; Humans; Isoniazid; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 1990 |